Fig. 1: PPV‑06 phase 1 study scheme.

Schematic representation of the clinical trial design showing the number of groups and participants, treatment schedule, and time intervals. EoS End of Study.

Schematic representation of the clinical trial design showing the number of groups and participants, treatment schedule, and time intervals. EoS End of Study.